Tag: US45782T1051

INmune Bio, Inc. Announces Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Boca Raton, Florida, June 27, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, today announced that it has entered into securities purchase agreements with two healthcare focused institutional investors for the purchase and sale of 3,000,000 shares of its common stock in a registered direct offering (the "Offering") at a purchase price of $6.30 per share, priced at-the-market under Nasdaq rules.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsUS45782T1051

InventHelp Inventor Develops New Beverage Accessory (TLS-807)

BexBack Launches Limited-Time $50 Bonus, 100% Deposit Bonus Match, 100x Leverage, and No KYC Amid Bitcoin Surge Past $100K

Lifeway Foods Comments on Edward and Ludmila Smolyansky’s Consent Solicitation and Urges Shareholders to Disregard the Unlawful Consent Solicitation Statement

Tag: US45782T1051

INmune Bio, Inc. Announces Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us